Cardiovascular and Neurological Conditions: A Review

Angina

Substernal pain caused by insufficient perfusion of the myocardium.

Angina Types

  • Stable: Oxygen demand exceeds supply, usually brought on by physical exertion.
    • Drug therapy: SL NTG, BB, or LA nitrate
  • Variant: Oxygen supply decreases due to vasospasm, may occur at rest.
    • Calcium channel blocker
  • Unstable: Oxygen supply decreases as demand increases; secondary to atherosclerotic plaque rupture within the coronary artery.
    • Combination e.g. CCB + BB

Drugs Used in Angina Pectoris

Vasodilators

Nitrates

Short,

Read More

Cardiac Measurements, ECG Findings, and Heart Conditions

Cardiac Measurements and Normal Values

This section provides normal values for various cardiac measurements obtained during echocardiography.

  • KSGDD (LV): N (Upper limit): 56
  • Indskas: N (Upper limit): 29
  • TSP (Interventricular Septum): N: 9-10
  • KSUS (Posterior Wall): N: 9-10
  • KS MM (LV): M: 105, W: 95
  • Mass Index: M: 105, W: 95
  • SSS (Relative Wall Thickness): [Table Data Missing – Requires Calculation]

Ejection Fraction (EF): N: 55+%

  • Low EF may indicate cardiomyopathy, heart attack, coronary artery disease, or
Read More

ECG Interpretation and Cardiovascular Management Essentials

ECG Interpretation and Cardiovascular Management

ECG Lead Locations and Waveform Analysis

  • II, III, aVF: Inferior leads
  • V1 & V2: Septal leads
  • V3 & V4: Anterior leads
  • I, aVL, V5 & V6: Lateral leads

Electrode Placement

RA (White), LA (Black), V (Brown)

Intervals and Segments

  • PR Interval: 0.12-0.20 seconds
    • Shorter PR: Impulse from AV junction
    • Longer PR: First-degree AV block
  • QRS Interval: 0.06-0.12 seconds
  • QT Interval: 0.39-0.43 seconds (Predisposes to Torsades de Pointes, intensified by low calcium
Read More

Pharmacology Quick Reference: Anticoagulants, Anemia, and Antiarrhythmics

Anticoagulants

Unfractionated Heparin (UFH)

  • Mechanism: Antithrombin III, Xa/IIa
  • Dosage:
    • Loading dose & continuous infusion: 80 units/kg load, 18 units/kg/h infusion
    • Prophylaxis: 5000 units subcutaneously
  • Contraindications: HIT (Heparin-Induced Thrombocytopenia), hypersensitivity, thrombocytopenia, active bleeding or risk of bleeding
  • Monitoring: aPTT (activated Partial Thromboplastin Time), baseline and every 6 hours until 2x therapeutic level; goal 1.5-2.5x baseline
  • Reversal Agent: Protamine sulfate

Low

Read More